MarketInOut Stock Screener Log In | Sign Up

Bristol Myers Squibb Co

XETRA • Healthcare • Drug Manufacturers - General • Quote as of 10/30/2026
Bristol Myers Squibb Co stock price and volume chart

Company Profile

IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeXETRA
Market Capitalization114,878 mln
Float2,038 mln
Earnings Date10/29/2026

EPS

3.88
Solid

P / E

14.48
Fair value

Piotroski F-Score

8 / 9
Very strong

Beneish M-Score

-2.57
Likely reliable

Relative Strength

87 / 100
Strongly outperforming

Debt / Equity

1.92
High leverage

Business Description

Founded in 1887 and based in Princeton, New Jersey, Bristol-Myers Squibb is a global biopharmaceutical company that researches, produces, and sells medicines across a wide range of serious health conditions, including cancer, blood disorders, heart disease, and immune system conditions. The company's portfolio includes well-known treatments such as Opdivo, Eliquis, Orencia, and Revlimid, among many others. Its products reach patients through wholesalers, pharmacies, hospitals, and government agencies around the world.

Key Fundamentals

EPS3.88
P/E14.48
ROE44.95
RPS21.89
ROIC20.02
ROA10.27
Interest Cover9.97
EBITDA, mln13,664
EV / EBITDA10.10
EV / EBIT12.36
Revenue, mln43,092
EV / Revenue3.21

Quote Details

Last 56.20
Change 1.94 (3.58%)
Open 55.45
Volume 487
Turnover 27,369
Average Volume 1,180.29

Financial Ratios

Pre-Tax Profit Margin23
Leverage Ratio3.79
Current Ratio1.59
Price / Book5.46
Price / Cash Flow11.98
Price / Free Cash Flow13.78
Debt / Equity1.92
Price / Sales2.56
PEG Ratio3.63

Financial Strength

Altman Z-Score2.7
Piotroski F-Score 8 / 9
Beneish M-Score-2.57
Price to Intrinsic Value0.91
Shiller PE Ratio35.39

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 1.9% 77 / 100   
1 Month 3.94% 72 / 100   
2 Months 1.39% 59 / 100   
6 Months 21.33% 91 / 100   
1 Year 46.93% 93 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog